ISI NucMed 2022 – Du 3 au 6 juin 2023, Nantes

During four days, 20 participants will deepen their knowledge in some of the main research areas in nuclear medicine, with a focus on alpha emitting radionuclides (astatine-211 in particular). They
Read More

A look back at … the Cancer and Work Meeting

The conference “Living and working with cancer” was held on Wednesday 23 November at the Cité des sciences et de l’industrie in Paris. This conference brought together more than 400
Read More

REWORK: A toolbox to facilitate the return to work

After 5 years of research, the REWORK programme of SIRIC ILIAD is about to release a toolbox for patients with breast cancer, which includes materials to help them return to
Read More

SIRIC ILIAD is proud to count Philippe Moreau as one of the most influential researchers in the world 2022

The annual Clarivate – Highly Cited Researchers ranking has, for the seventh consecutive year, recognised Professor Philippe Moreau, Director of SIRIC ILIAD, as a Highly Cited Researcher in 2022. On
Read More

Modeling tumor development and progression: From PDXs to cancer organoids | A colloquium sponsored by SIRIC ILIAD

On October 18th, the French PDX network and the Organoids research group organised, with the support of the SIRIC ILIAD and the CRCI²NA, a hybrid colloquium : Modeling tumor development
Read More

New AF3M newsletter: AIDES & RIGHTS

As part of the National Multiple Myeloma Information Day (JNM 2022) of the AF3M (Association Française des Malades du Myélome Multiple), the association has released a new information bulletin entitled
Read More